Journal article
Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study
Abstract
BACKGROUND AND PURPOSE: The optimal duration of venous thromboembolism prophylaxis in acute stroke patients is unknown. This subanalysis of the Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization (EXCLAIM) study investigated extended-duration thromboprophylaxis with enoxaparin, compared with placebo following standard-duration enoxaparin, in ischemic stroke patients.
METHODS: Acutely ill …
Authors
Turpie AGG; Hull RD; Schellong SM; Tapson VF; Monreal M; Samama M-M; Chen M; Yusen RD; Investigators FTE
Journal
Stroke, Vol. 44, No. 1, pp. 249–251
Publisher
Wolters Kluwer
Publication Date
January 2013
DOI
10.1161/strokeaha.112.659797
ISSN
0039-2499